FR 115427

Known as: FR-115427, FR115427 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2014
012319932014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Lithiation of N-Boc-1-phenyltetrahydroisoquinolines was optimized by in situ IR spectroscopy. The kinetics for rotation of the… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
1998
1998
Longitudinal muscle-myenteric plexus strips of the guinea pig ileum were used to investigate a possible transmitter role of… (More)
Is this relevant?
1996
1996
Recent studies indicate that competitive and non-competitive NMDA receptor antagonists can be readily distinguished by their… (More)
Is this relevant?
1996
1996
A series of 1,2,3,4-tetrahydroisoquinoline derivatives were synthesized and evaluated for anticonvulsant activity against… (More)
Is this relevant?
1996
1996
Novel 4,5,6,7-tetrahydrothieno[3,2-c]pyridines, 1-thienyl-1,2,3,4-tetrahydroisoquinolines and related compounds, in which the… (More)
Is this relevant?
1995
1995
The present study was carried out to compare the neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427… (More)
Is this relevant?
1995
1995
Behavioral and in vitro receptor binding methods were used to evaluate and compare the effects of FR115427 ((+)-1-methyl-1-phenyl… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1995
1995
Primary culture of cerebral cortical neurons from mouse embryo was treated with non-competitive N-methyl-D-aspartate (NMDA… (More)
Is this relevant?
1994
1994
Excitatory amino acids and their receptors have been postulated to be involved in mediating ischemic neuronal damage. We occluded… (More)
Is this relevant?
1993
1993
The pharmacological profile of FR115427 has been examined using ligand binding and electrophysiological techniques. Binding of… (More)
Is this relevant?